Table 2 Molecular diagnosis
From: Clinical evaluation of a dedicated next generation sequencing panel for routine glioma diagnostics
Number of cases (%) | |
|---|---|
No mutations identified | 19 (4.4) |
Unclassifying mutations | 37 (8.5) |
Astrocytoma | 117 (27.0) |
Oligodendroglioma | 54 (12.5) |
Glioblastoma | 179 (41.3) |
H3F3A K27 M-mutated tumor | 9 (2.1) |
H3F3A G34 M-mutated tumor | 3 (0.7) |
BRAF-mutated tumor | 15 (3.5) |
Total | 434 |